Microdose Tirzepatide | Peptide Therapy

 

What is Microdosing?

Microdosing involves starting patients on lower doses of GLP-1 medications than typically prescribed. The goal is to minimize side effects while still achieving some of the benefits associated with these drugs.

Potential Benefits of Microdosing:

-Reduced gastrointestinal side effects
-Gradual adjustment to the medication
-Potentially lower initial costs for patients

Important Considerations:

-Efficacy may be reduced at lower doses
-It may take longer to see significant results
-Not all patients will benefit from this approach

The Practicalities of Microdosing

One crucial aspect of microdosing is the method of delivery. Compounded medications offer more flexibility in dosing, making microdosing easier to implement. However, with brand-name medications like Wegovy and Zepbound, which come in prefilled, pre-dosed pens, microdosing can be challenging or even impossible.

Eli Lilly has recently introduced vials of their medication in 2.5 mg and 5 mg doses, which could potentially allow for microdosing. However, given the high prices set by the company, this approach could quickly become very expensive for patients.

Is Microdosing Right for Everyone?

It’s important to note that while microdosing is gaining popularity, it’s not the standard of care. The FDA-approved dosing regimens have been rigorously tested for safety and efficacy. Any deviation from these standards should be done cautiously and under close medical supervision.

The decision to microdose should be made on an individual basis, considering factors such as medical history, treatment goals, and financial considerations. What works for one patient may not work for another, highlighting the importance of personalized medical care.